4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001179110-19-006616
Director bought 3,500 shares at $22.33 ($78,155)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Saad Mark E Director | 2019-05-23 | Purchase | +3,500 | $22.33 | $78,155 | 7,002 | D: show line 1 in the form |
| Open-market purchases · 3,500 sh · avg $22.33 · $78,155 | |||||||
Loading xslF345X03/edgar.xml…